These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2890782)

  • 1. Positive inotropic action of kappa opiate agonists, ethylketocyclazocine and dynorphin-A(1-13), in isolated rat atrium.
    Maeda S; Nakamae J; Inoki R
    Jpn J Pharmacol; 1987 Sep; 45(1):125-8. PubMed ID: 2890782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cardiac Na+, K+-ATPase activity by dynorphin-A and ethylketocyclazocine.
    Maeda S; Nakamae J; Inoki R
    Life Sci; 1988; 42(4):461-8. PubMed ID: 2893234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.
    Laurent S; Schmitt H
    Eur J Pharmacol; 1983 Dec; 96(1-2):165-9. PubMed ID: 6319158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones.
    Knox RJ; Dickenson AH
    Brain Res; 1987 Jul; 415(1):21-9. PubMed ID: 2887243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite central cardiovascular effects of various morphine-like drugs and opiate peptides in the rat.
    Laurent S; Schmitt H
    Eur Heart J; 1983 Nov; 4 Suppl G():61-5. PubMed ID: 6363080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of stimulation strength in mouse vas deferens on inhibition of neuroeffector transmission by receptor type selective opioids.
    Ramme D; Illes P
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):57-61. PubMed ID: 2869418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
    Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M
    Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynorphin-(1-13) restores the potency of morphine on the tolerant guinea pig ileum.
    Rezvani A; Way EL
    Eur J Pharmacol; 1984 Jul; 102(3-4):475-9. PubMed ID: 6149134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Centrally-administered opioid selective agonists inhibit drinking in the rat.
    Spencer RL; Deupree D; Hsiao S; Mosberg HI; Hruby V; Burks TF; Porreca F
    Pharmacol Biochem Behav; 1986 Jul; 25(1):77-82. PubMed ID: 2875475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic opioid receptors modulating acetylcholine release in the hippocampus of the rabbit.
    Jackisch R; Geppert M; Brenner AS; Illes P
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):156-62. PubMed ID: 2871497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological effects of dynorphin peptides on hippocampal pyramidal cells in rat.
    Moises HC; Walker JM
    Eur J Pharmacol; 1985 Jan; 108(1):85-98. PubMed ID: 2858395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Ca++-ATPase of rat erythrocyte membranes by k-opioid agonists.
    Yamasaki Y; Way EL
    Neuropeptides; 1985 Feb; 5(4-6):359-62. PubMed ID: 2860593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone's effect on the inotropic and chronotropic responses of isolated, electrically stimulated or spontaneously beating rat atria.
    Thornhill J; St Onge R; Gregor L
    Can J Physiol Pharmacol; 1990 Mar; 68(3):392-401. PubMed ID: 2322896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity to dynorphin-(1-13) of the presynaptic inhibitory opiate receptors of the guinea-pig heart.
    Ledda F; Mantelli L; Corti V
    Eur J Pharmacol; 1985 Nov; 117(3):377-80. PubMed ID: 2866973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kappa-receptor mechanisms in synaptosomal Ca uptake.
    Toru T; Konno F; Takayanagi I; Hirobe M
    Gen Pharmacol; 1989; 20(2):249-52. PubMed ID: 2565850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the opioid receptor subtype inhibiting the evoked release of 3H-noradrenaline from guinea-pig atria in vitro.
    Fuder H; Buder M; Riers HD; Rothacher G
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):148-55. PubMed ID: 2871496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of opioid receptors modulating noradrenaline release in the hippocampus of the rabbit.
    Jackisch R; Geppert M; Illes P
    J Neurochem; 1986 Jun; 46(6):1802-10. PubMed ID: 2871130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine.
    Shearman GT; Schulz R; Schiller PW; Herz A
    Psychopharmacology (Berl); 1985; 85(4):440-3. PubMed ID: 2862651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kappa agonists inhibit gastric emptying but not acid secretion in rhesus monkeys.
    Touzeau PL; Shea-Donohue T
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1010-6. PubMed ID: 1972746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.